Vasomotor symptoms, including hot flashes and night sweats, are the most frequently
reported symptoms of the menopausal transition. Although prevalence rates vary substantially
across populations of menopausal women, the vast majority of women in the United States
will experience hot flashes at some point during menopause. Other groups of people
also experience hot flashes, including breast cancer survivors and men undergoing
androgen deprivation therapy.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Mayo Clinic ProceedingsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
REFERENCES
- Estrogen plus progestin and the risk of coronary heart disease.N Engl J Med. 2003; 349: 523-534
- Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.JAMA. 2003; 289: 2673-2684
- Estrogen and Estrogen with Progestin Therapies for Postmenopausal Women.Available at: www.fda.gov/womens/menopause/(Accessibility verified May 11, 2004.)Date: April 29, 2004
- Feasibility and psychometrics of an ambulatory hot flash monitoring device.Menopause. Fall 1999; 6: 209-215
- Laboratory and ambulatory monitoring of menopausal hot flashes.Psychophysiology. 1989; 26: 573-579
- Menopausal hot flashes.in: Lobo RA Kelsey J Marcus R Menopause: Biology and Pathobiology. Academic Press, San Diego, Calif2000: 215-227
- Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes.Fertil Steril. 1998; 70: 332-337
- Reduced thermoregulatory null zone in postmenopausal women with hot flashes.Am J Obstet Gynecol. 1999; 181: 66-70
- Vasomotor symptoms, serum estrogens, and gonadotropin levels in surgical menopause.Am J Obstet Gynecol. 1976; 126: 165-169
- Postmenopausal symptomatology, maturation index, and plasma estrogen levels.Obstet Gynecol. 1975; 45: 625-627
- Alpha 2-adrenergic mechanism in menopausal hot flushes.Obstet Gynecol. 1990; 76: 573-578
- Relation between plasma oestrone and oestradiol and climacteric symptoms.Lancet. 1978; 1: 678-681
- Core body temperature and circadian rhythm of hot flashes in menopausal women.J Clin Endocrinol Metab. 1995; 80: 2354-2358
- Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women.Fertil Steril. 2000; 74: 20-23
- Further delineation of hypothalamic dysfunction responsible for menopausal hot flashes.J Clin Endocrinol Metab. 1984; 59: 1097-1102
- Hot flashes in patients with hypogonadism and low serum gonadotropin levels.Endocr Pract. 2003; 9: 119-123
- Pituitary hormones during the menopausal hot flash.Obstet Gynecol. 1984; 64: 752-756
Article Info
Identification
Copyright
© 2004 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Menopause and Hot Flashes: No Easy Answers to a Complex ProblemMayo Clinic ProceedingsVol. 79Issue 6
- PreviewThe highly publicized findings of the Women's Health Initiative1,2 have increased the pressure on the medical community to find safe and alternative medications for female health, especially for hot flashes. Hot flashes are a common symptom experienced by postmenopausal women. In their severest form, hot flashes result in sleep deprivation and mood disorders. Women from varying ethnic backgrounds experience menopause in different ways. As a result, many studies have focused on hot flashes as a definable, yet subjective end point to test efficacy of various drugs, behavioral therapies, and herbal preparations.
- Full-Text
- Preview
